Comparative Study of Antitumor Efficiency of Intraperitoneal and Intravenous Cytostatics in Experimental Rats with Disseminated Ovarian Cancer
- 作者: Bespalov V.1,2, Vyshinskaya E.1, Vasil’eva I.1,2, Semenov A.1,2, Maidin M.1, Barakova N.2, Stukov A.1
-
隶属关系:
- Research Laboratory of Cancer Chemoprophylaxis and Oncopharmacology, I. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation
- International Research Centre “Biotechnologies of the Third Millennium”, ITMO University (St. Petersburg National Research University of Information Technologies, Mechanics and Optics
- 期: 卷 162, 编号 3 (2017)
- 页面: 383-386
- 栏目: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/238232
- DOI: https://doi.org/10.1007/s10517-017-3621-5
- ID: 238232
如何引用文章
详细
Antitumor efficiencies of cytostatics dioxadet, cisplatin, mitomycin C, melphalan, and paclitaxel after a single intraperitoneal or intravenous injection in doses of 1.5, 4, 1.5, 2, and 5 mg/kg, respectively, were studied on the model of transplanted ovarian tumor in 124 rats. The antitumor effects were evaluated by the increase in median survival. Dioxadet, cisplatin, and melphalan injected intraperitoneally significantly prolonged the lifespan median – by 79, 88, and 114%, respectively, and were in fact ineffective, when injected intravenously. Intraperitoneal mitomycin C prolonged lifespan median by just 35%, intravenous – by 152%. Paclitaxel injected intraperitoneally and intravenously prolonged the lifespan median by 45 and 81%, respectively.
作者简介
V. Bespalov
Research Laboratory of Cancer Chemoprophylaxis and Oncopharmacology, I. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation; International Research Centre “Biotechnologies of the Third Millennium”, ITMO University (St. Petersburg National Research University of Information Technologies, Mechanics and Optics
Email: iravasilyeva@hotmail.com
俄罗斯联邦, St. Petersburg; St. Petersburg
E. Vyshinskaya
Research Laboratory of Cancer Chemoprophylaxis and Oncopharmacology, I. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation
Email: iravasilyeva@hotmail.com
俄罗斯联邦, St. Petersburg
I. Vasil’eva
Research Laboratory of Cancer Chemoprophylaxis and Oncopharmacology, I. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation; International Research Centre “Biotechnologies of the Third Millennium”, ITMO University (St. Petersburg National Research University of Information Technologies, Mechanics and Optics
编辑信件的主要联系方式.
Email: iravasilyeva@hotmail.com
俄罗斯联邦, St. Petersburg; St. Petersburg
A. Semenov
Research Laboratory of Cancer Chemoprophylaxis and Oncopharmacology, I. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation; International Research Centre “Biotechnologies of the Third Millennium”, ITMO University (St. Petersburg National Research University of Information Technologies, Mechanics and Optics
Email: iravasilyeva@hotmail.com
俄罗斯联邦, St. Petersburg; St. Petersburg
M. Maidin
Research Laboratory of Cancer Chemoprophylaxis and Oncopharmacology, I. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation
Email: iravasilyeva@hotmail.com
俄罗斯联邦, St. Petersburg
N. Barakova
International Research Centre “Biotechnologies of the Third Millennium”, ITMO University (St. Petersburg National Research University of Information Technologies, Mechanics and Optics
Email: iravasilyeva@hotmail.com
俄罗斯联邦, St. Petersburg
A. Stukov
Research Laboratory of Cancer Chemoprophylaxis and Oncopharmacology, I. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation
Email: iravasilyeva@hotmail.com
俄罗斯联邦, St. Petersburg